Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Source Denies AstraZeneca-Bristol Myers Squibb Merger Talks

Pharmaceutical Executive Daily: Source Denies AstraZeneca-Bristol Myers Squibb Merger Talks

Published 3 months, 1 week ago
Description
In today's Pharmaceutical Executive Daily, a senior source denies reports of merger talks between AstraZeneca and Bristol Myers Squibb, CSPC Pharmaceutical and AstraZeneca form a joint venture for biologics manufacturing in China, and a feature examines how U.S. Patent and Trademark Office policy changes are slowing patent challenges for generic and biosimilar drugmakers.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us